New Harvard Study Confirms Big Pharma & Federal Govt Root Cause of Opioid Epidemic

Subscribe
Share

Source: thefreethoughtproject.com/Justin Gardner

A new study published in the Harvard Law & Policy Review painstakingly describes how Big Pharma deception and federal government patenting have brought about the current U.S. opioid epidemic. As lawsuits pile up against pharma companies, this study confirms that for 20 years, the American public has served as the victim in a gargantuan scheme of money and power.

The study, titled The Opioid Epidemic: Fixing a Broken Pharmaceutical Market, gets right to the point in the introduction.

“In this article, we argue that non-rigorous patenting standards and ineffectual policing of both fraudulent marketing and anti-competitive actions played an important role in launching and prolonging the opioid epidemic. We further show that these regulatory issues are not unique to prescription opioids but rather are reflective of the wider pharmaceutical market.”

Researchers follow with a primer on the rise of opioid prescriptions and how pain became “the fifth vital sign.” By the 1990s, doctors realized that chronic pain was often ignored, and pain management became a hot topic. Physicians were urged to make greater use of opioids, with experts in the field downplaying the potential for misuse and addiction – a view largely based on experience with morphine.

But this was before OxyContin came along.

Purdue Pharma, recognizing that this newfound view of the medical establishment could be exploited, worked to develop an improved synthetic opioid. Their golden ticket was found with the extended-release oxycodone pill known as OxyContin, patented and approved by the FDA in 1995.

However, Purdue’s exclusive patent was based on corporate fraud and government ignorance.

Read More…

Share

Leave a Reply

Your email address will not be published. Required fields are marked *